SEC Tracker
Get the app

Aptevo Therapeutics APVO

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
Exhibit 99.1
Press release
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Aptevo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Traws Pharma ONTX public float $10M, Jun 30, 2025
  2. Mannatech MTEX public float $10M, Jun 30, 2025
  3. LeonaBio ATHA public float $10M, Jun 30, 2025
  4. BioCardia BCDA public float $10M, Jun 30, 2025
  5. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025